Asher M Marks (Asher Marks)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 5

Top Topics

Alcohol Consumption

Metastatic Colorectal Cancer

Top Venues

Pediatric blood & cancer

Journal of medical Internet research

JMIR research protocols

Advances in neonatal care : official journal of the National Association of Neonatal Nurses

This page only lists publications with an associated author ORCID identifier.

Publications

Veronica U Weser, Abigail Crocker, Thomas S Murray, Jayson Wright, Erin J K Truesdell, Rebecca Ciaburri, Asher M Marks, Richard A Martinello, Kimberly D Hieftje, null null
Barriers to Effective Infection Prevention in the Neonatal Intensive Care Unit: A Qualitative Study. Advances in neonatal care : official journal of the National Association of Neonatal Nurses 24 (5) (2024)
Asher M Marks, Amanda Garbatini, Kimberly D Hieftje, Vidya Puthenpura, Veronica U Weser, Claudia-Santi F Fernandes
Use of Immersive Virtual Reality Spaces to Engage Adolescent and Young Adult Patients With Cancer in Therapist-Guided Support Groups: Protocol for a Pre-Post Study. JMIR research protocols 12 (2023)
Scott C Roberts, Nancy L Havill, Rosa M Flores, Curtis Anthony Hendrix Ii, Maximillian J Williams, Richard S Feinn, Steven J Choi, Richard A Martinello, Asher M Marks, Thomas S Murray
Disinfection of Virtual Reality Devices in Health Care Settings: In Vitro Assessment and Survey Study. Journal of medical Internet research 24 (12) (2022)
Vidya Puthenpura, Maureen E Canavan, Jenny N Poynter, Michael Roth, Farzana D Pashankar, Beth A Jones, Asher M Marks
Racial/ethnic, socioeconomic, and geographic survival disparities in adolescents and young adults with primary central nervous system tumors. Pediatric blood & cancer 68 (7) (2021)
Asher M Marks, Ranjit S Bindra, Michael L DiLuna, Anita Huttner, Vikram Jairam, Kristopher T Kahle, Mark W Kieran
Response to the BRAF/MEK inhibitors dabrafenib/trametinib in an adolescent with a BRAF V600E mutated anaplastic ganglioglioma intolerant to vemurafenib. Pediatric blood & cancer 65 (5) (2018)